Patents by Inventor Susan Boyd

Susan Boyd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF MPTP
    Publication number: 20260007672
    Abstract: The invention relates to compounds of formula (I), and related aspects.
    Type: Application
    Filed: September 9, 2025
    Publication date: January 8, 2026
    Applicant: NRG Therapeutics Ltd
    Inventors: Neil MILLER, Gilles OUVRY, Richard RUTTER, Tammy LADDUWAHETTY, Christopher THOMSON, Jan KULAGOWSKI, Michael ROWLEY, Andrew TUFFNELL, Gabriel NEGOITA-GIRAS, Mark STEWART, Rachel ARMSTRONG, Susan BOYD
  • Inhibitors of mPTP
    Patent number: 12491185
    Abstract: The invention relates to compounds of formula (I), and related aspects.
    Type: Grant
    Filed: January 16, 2025
    Date of Patent: December 9, 2025
    Assignee: NRG THERAPEUTICS LTD
    Inventors: Neil Miller, Gilles Ouvry, Richard Rutter, Tammy Ladduwahetty, Christopher Thomson, Jan Kulagowski, Michael Rowley, Andrew Tuffnell, Gabriel Negoita-Giras, Mark Stewart, Rachel Armstrong, Susan Boyd
  • INHIBITORS OF MPTP
    Publication number: 20250177397
    Abstract: The invention relates to compounds of formula (I), and related aspects.
    Type: Application
    Filed: January 16, 2025
    Publication date: June 5, 2025
    Applicant: NRG Therapeutics Ltd
    Inventors: Neil MILLER, Gilles OUVRY, Richard RUTTER, Tammy LADDUWAHETTY, Christopher THOMSON, Jan KULAGOWSKI, Michael ROWLEY, Andrew TUFFNELL, Gabriel NEGOITA-GIRAS, Mark STEWART, Rachel ARMSTRONG, Susan BOYD
  • INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS
    Publication number: 20220073470
    Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.
    Type: Application
    Filed: January 3, 2020
    Publication date: March 10, 2022
    Inventors: Robert G. Lowery, Meera Kumar, Matthew Boxer, David Maloney, Susan Boyd
  • INHIBITORS OF CGAS ACTIVITY AS THERAPEUTIC AGENTS
    Publication number: 20220073532
    Abstract: This disclosure relates to compounds, pharmaceutical compositions comprising them, and methods of using the compounds and compositions for treating or preventing inappropriate activation of a type I interferon (IFN) response in a subject in need thereof.
    Type: Application
    Filed: January 3, 2020
    Publication date: March 10, 2022
    Inventors: Robert G. Lowery, Meera Kumar, Matthew Boxer, David Maloney, Susan Boyd